Cite
HARVARD Citation
de Hoon, J. et al. (2018). Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine. Clinical pharmacology & therapeutics. 103 (5), pp. 815-825. [Online].